Table 2 BRB consumption decreased UBT and inflammatory markers, and oxidative indexes

From: Black raspberry supplementation on overweight and Helicobacter pylori infected mild dementia patients a pilot study

 

Week 0

Week 8

Follow up

UBT

 BRBs

22.12 ± 4.14

9.36 ± 6.36a

16.82 ± 10.46a

 Placebo

22.98 ± 1.78

22.99 ± 2.065

22.88 ± 3.07

Inflammatory markers

 TNF-α (pg/mL)

 BRBs

19.76 ± 4.65

6.85 ± 3.27a

7.97 ± 2.17a

 Placebo

19.81 ± 2.21

19.59 ± 2.31

19.41 ± 2.39

 IL-1β (pg/mL)

 BRBs

0.16 ± 0.07

0.12 ± 0.05a

0.18 ± 0.05a

 Placebo

0.19 ± 0.08

0.19 ± 0.05

0.18 ± 0.05

 IL-8 (pg/mL)

 BRBs

7.61 ± 5.10

4.63 ± 3.63a

5.94 ± 3.09

 Placebo

7.67 ± 4.25

7.86 ± 4.90

7.79 ± 4.23

 COX-2 (ng/mL)

 BRBs

1.74 ± 0.71

0.87 ± 0.56a

0.88 ± 0.50a

 Placebo

1.68 ± 0.65

1.64 ± 0.72

1.69 ± 0.62

 iNOS (ng/mL)

 BRBs

21.15 ± 8.50

20.27 ± 10.28

22.37 ± 11.95

 Placebo

21.73 ± 7.44

22.00 ± 7.75

21.21 ± 7.24

Oxidative

indexes

 SOD (U/mL)

 BRBs

696.42 ± 35.30

784.86 ± 46.13a

743.84 ± 55.59a

 Placebo

690.72 ± 34.84

695.44 ± 39.65

691.54 ± 41.35

 CAT (U/mL)

 BRBs

346.11 ± 14.60

360.84 ± 8.26a

360.21 ± 9.22a

 Placebo

352.58 ± 14.16

351.95 ± 11.30

351.14 ± 9.03

 TBARS (µmol/L)

 BRBs

4.14 ± 1.20

1.20 ± 0.35a

1.97 ± 0.62a

 Placebo

4.20 ± 0.57

4.25 ± 0.74

4.30 ± 0.90

 TEAC (µmol Trolox/L)

 BRBs

1319.77 ± 191.90

1840.68 ± 188.73a

1740.09 ± 155.99a

 Placebo

1250.90 ± 185.14

1232.00 ± 199.59

1238.40 ± 237.70

  1. The results are expressed as mean ± SD.
  2. aDifference between different times and week 0 within the same group, P < 0.05.